3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
10
Ovarian Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Lung Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Rectal Neoplasms
2
Melanoma
2
Liver Neoplasms
2
Head and Neck Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Urethral Neoplasms
1
Tobacco Use Disorder
1
Recurrence
1
Precancerous Conditions
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neoplasms
1
Neoplasm Metastasis
1
Kidney Neoplasms
1
Hirschsprung Disease
1
Glioma
1
Ganglion Cysts
1
Gallbladder Neoplasms
1
Endometrial Neoplasms
1
Interventions
Trastuzumab
2
toripalimab
1
pyrotinib
1
Vinblastine
1
Transurethral Resection of Bladder
1
Thalidomide
1
TP protocol
1
Sodium Chloride
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Positron Emission Tomography Computed Tomography
1
Paclitaxel
1
Neoadjuvant Therapy
1
Metformin
1
Magnetic Resonance Imaging
1
Immunohistochemistry
1
Esophagectomy
1
Endoscopy
1
Dynamic Contrast Enhanced Magnetic Resonance Imaging
1
Diffusion Magnetic Resonance Imaging
1
Dexamethasone
1
Decitabine
1
Cytarabine
1
Cisplatin
1
Chemoradiotherapy
1
Cell-Free Nucleic Acids
1
Carboplatin
1
Bortezomib
1
Blood Specimen Collection
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Pathologic Complete Response
×
Immunohistochemistry
×
Clear all
NCT04917263
2021-06-08
IMMUNOREACT2
University of Padova
Unknown
544 enrolled